FDA Fast-Tracks 3 Psychedelic Therapies — What It Means for Our Patients
Three companies just received National Priority Review Vouchers, which means their therapies will be reviewed in one to two months instead of the usual twelve.
Three companies just received National Priority Review Vouchers, which means their therapies will be reviewed in one to two months instead of the usual twelve.